Rutaecarpine, a Quinazolinocarboline Alkaloid, Inhibits Prostaglandin Production in RAW264.7 Macrophages

Abstract

In order to delineate the mechanism involved in the anti-inflammatory activity of rutaecarpine, its effects on the production of prostaglandin (PG) and therein involved enzymes were examined. Rutaecarpine reduced the production of PGE₂ in RAW264.7 cells treated with lipopolysaccharide (LPS) in a dose dependent manner when added to the culture media at the time of stimulation. However, the inhibition of total cellular cyclooxygenase (COX) activity under the same experimental condition was observed only at high concentrations of rutaecarpine. Rutaecarpine did not affected the levels of COX-2 mRNA and protein in macrophages stimulated with LPS. Calcium ionophore A23187 induced-PG production and [³ H]-arachidonic acid release were significantly decreased by the pretreatment of rutaecarpine for 30 minutes. With the same treatment schedule, however, rutaecarpine failed to alter the activities of cellular COX-1 and COX-2. Collectively, our data suggest that anti-inflammatory effect of rutaecarpine is, at least in part, ascribed to the diminution of PG production through inhibition of arachidonic acid release albeit the nature of its effects on PLA₂ activity remains to be elaborated.

Evodia rutaecarpa - Rutaceae - rutaecarpine - prostaglandin - cyclooxygenase - phospholipase A₂

References

• 1 Sheu J R, Hung W C, Lee Y M, Yen M H. Mechanism of inhibition of platelet aggregation by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa. Eur. J.  Pharmacol.. 1996;  318 469-75
• 2 Kametani T. Rutaecarpine, Jpn. Kokai Tokkyo Koho,. Japan Patent Office Tokyo; 1977: 1105-6
• 3 King C L, Kong Y C, Wong N S, Yeung H W, Fong H H, Sankawa U. Uterotonic effect of Evodia rutaecarpa alkaloids. J. Nat.  Prod.. 1980;  43 577-82
• 4 Chiou W F, Chou C J, Liao J F, Shum A YC, Chen CF. The mechanism of the vasodilator effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa. Eur. J.  Pharmacol.. 1994;  257 59-66
• 5 Wang G J, Shan J, Pang P KT, Yang M CM, Chou CJ, Chen C F. The vasorelaxing action of rutaecarpine: direct paradoxical effects on intracellular calcium concentration of vascular smooth muscle and endothelial cells. J. Pharmacol. Exp.  Ther.. 1996;  276 1016-21
• 6 Yamahara J, Yamada T, Kitani T, Naitoh Y, Fujimura H. Antianoxic action and active constituents of evodiae fructus. Chem. Pharm.  Bull.. 1989;  37 1820-2
• 7 Yamahara J, Yuasa K, Isono M, Suekawa M. Cerebral function improving agent containing evodiamine or rutaecarpine. Jpn. Kokai Tokkyo Koho,. Japan Patent Office Tokyo; 1988: 155-8
• 8 Sheu J R, Kan Y C, Hung W C, Su C H, Lin C H, Lee Y M, Yen M H. The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C. Thromb.  Res.. 1998;  92 53-64
• 9 Matsuda H, Wu J X, Tanaka T, Iinuma M, Kubo M. Antinociceptive activities of 70 % methanol extract of evodiae fructus (fruit of Evodia rutaecarpa var. bodinieri) and its alkaloidal components. Biol. Pharm.  Bull.. 1977;  20 243-8
• 10 Kametani T, Higa T, Loc C V, Ihara M, Koizumi M, Fukumoto K. Iminoketene cycloaddition. 1. A facile synthesis of quinazolone system by condensation of iminoketene with imines - A total synthesis of evodiamine and rutaecarpine by retro mass-spectral synthesis. J. Am. Chem.  Soc.. 1976;  98 6186-8
• 11 Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol.  Meth.. 1983;  65 55-63
• 12 Lee S H, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D, Hwang D H. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol.  Chem.. 1992;  267 25 934-8
• 13 DeWitt D L, Meade E A. Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes. Arch. Biochem.  Biophys.. 1993;  306 94-102
• 14 Qiu Z H, Gijon M A, de Carvalho M S, Spencer D M, Leslie C C. The role of calcium and phosphorylation of cytosolic phospholipase A₂ in regulating arachidonic acid release in macrophages. J. Biol.  Chem.. 1998;  273 8203-11
• 15 Moon T C, Murakami M, Kudo I, Son K H, Kim H P, Kang S S, Chang H W. A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa. Inflamm.  Res.. 1999;  48 621-5
• 16 Balsinde J, Balboa M A, Insel P A, Dennis E A. Regulation and inhibition of phospholipase A₂. Annu. Rev. Pharmacol.  Toxicol.. 1999;  39 175-89
• 17 Pairet M, Ryn J V. Experimental models used to investigate the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 by non-steroidal anti-inflammatory drugs. Inflamm.  Res.. 1998 (supplement 2);  47 S93-101
• 18 Leung L K, Glauert H P. Effect of the peroxisome proliferator ciprofibrate on hepatic cyclooxygenase and phospholipase A₂ in rats.  Toxicology. 1998;  126 65-73
• 19 Otto J C, DeWitt D L, Smith W L. N-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. J. Biol.  Chem.. 1993;  268 18 234-42